港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

抗疫概念

908.714

-13.957-1.51%

涨家数：4

跌家数：12

平家数：2

市盈率：- -

高：927.380

开：922.866

低：906.728

收：922.671

数据加载中...

总览新闻资讯

四环医药05月08日遭主力抛售183.4万元

中国中药(00570)出现大手卖出110万股，成交价$2.08，涉资228.8万

阿斯达克财经

中证香港300中游指数报1032.38点，前十大权重包含比亚迪电子等

关税动荡日，名私募们的仓位都在近年来的高点……

消息称特斯拉中国4月份批发销量不到6万辆同比环比双双下滑

【券商聚焦】中泰国际5月医药行业投资策略：续推高附加价值的创新药生产商

76亿并购梦碎、15个月努力归零，负增长下的新诺威危机四伏

中国生物制药(01177)出现大手卖出150万股，成交价$3.85，涉资577.5万

阿斯达克财经

北京免疫方舟医药科技有限公司药品申请临床试验默示许可获受理

同源康医药-B盘中异动快速跳水5.02%

罗氏宣布投资超20亿人民币在沪新建生物制药生产基地

歌礼制药-B：股价涨 3.32% 减肥药催化

快递总裁收入曝光：李杰、刘强东、王卫，谁是快递行业的超级霸总

歌礼制药-B股价上涨超3% 将公布肥胖症药物早期研究结果

港股异动 | 歌礼制药-B(01672)涨超3% 将公布肥胖症候选药物ASC47早期研究结果

比亚迪(01211.HK)及青山控股退出智利锂生产投资

阿斯达克财经

开拓药业扳回一局

比亚迪申请一种负极片及其制备方法等专利，减少负极片膨胀提升电池循环性能

恒生指数、恒生科技指数盘初转涨，新能源物料、医药外包概念、军工股等涨幅居前。

人工智能赋能医药全产业链！“智造”创新药指日可待？

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1515/news?page=8"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":908.7142,"timestamp":1747123711734,"preClose":922.6707,"halted":0,"volume":315370946,"delay":0,"changeRate":-0.015126,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-13.956543,"latestTime":"05-13 16:00:00","open":922.8655,"high":927.38025,"low":906.72766,"amount":3207017304,"amplitude":0.022383,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747186200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1747099800000,1747108800000],[1747112400000,1747123200000]],"pbRate":1.617726,"peRate":21.639565,"turnoverRate":0.004069,"increases":4,"decrements":13,"flats":1,"marketCap":625646477440,"floatMarketCap":515989849088},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":927.38025,"amplitude":0.022383,"preClose":922.6707,"low":906.72766,"pbRate":"1.617726","latestPrice":908.7142,"volume":315370946,"delay":0,"open":922.8655,"prevYearClose":787.97723,"prevWeekClose":896.528,"prevMonthClose":903.998,"prevQuarterClose":870.015,"fiveDayClose":906.773,"twentyDayClose":771.593,"sixtyDayClose":858.56,"secType":"PLATE","market":"HK","turnoverRate":0.004069,"peRate":21.639565,"marketCap":625646477440,"floatMarketCap":515989849088,"timestamp":1747123711734,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":4,"down":12,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533906702","title":"四环医药05月08日遭主力抛售183.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533906702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533906702?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 16:15","pubTimestamp":1746692135,"startTime":"0","endTime":"0","summary":"05月08日, 四环医药股价跌1.39%，报收0.71元，成交金额1549.0万元，换手率0.23%，振幅4.17%，量比0.49。四环医药今日主力资金净流出183.4万元，上一交易日主力净流出47.5万元。该股近5个交易日下跌2.74%，主力资金累计净流入459.2万元；近20日主力资金累计净流入4152.0万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508173545a6d7724b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508173545a6d7724b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1191","00460","BK1600","BK1515"],"gpt_icon":0},{"id":"2533973012","title":"中国中药(00570)出现大手卖出110万股，成交价$2.08，涉资228.8万","url":"https://stock-news.laohu8.com/highlight/detail?id=2533973012","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533973012?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 16:08","pubTimestamp":1746691680,"startTime":"0","endTime":"0","summary":"[大手成交]中国中药(00570)在下午04:08出现大手卖出，成交量为110万，成交价为港币$2.08，涉资228.8万。至目前为止，股价无升跌，今日最高价为$2.1，而最低价为$2.06，总成交量为1.425千万股，总成交金额港币$2.966千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2505089317/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","00570","BK1191","BK1606"],"gpt_icon":0},{"id":"2533759509","title":"中证香港300中游指数报1032.38点，前十大权重包含比亚迪电子等","url":"https://stock-news.laohu8.com/highlight/detail?id=2533759509","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533759509?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 15:52","pubTimestamp":1746690767,"startTime":"0","endTime":"0","summary":"数据统计显示，中证香港300中游指数近一个月上涨17.40%，近三个月下跌6.65%，年至今上涨5.11%。从中证香港300中游指数持仓的市场板块来看，香港证券交易所占比100.00%。从中证香港300中游指数持仓样本的行业来看，信息技术占比47.49%、工业占比36.94%、原材料占比8.89%、可选消费占比5.02%、通信服务占比1.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050816234694f03ab4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050816234694f03ab4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00285","BK1607","BK1580","BK1504","BK1149","LU0274383008.USD","LU0348766576.USD","BK1589","BK1540","BK1582","LU0348767384.USD","BK1515"],"gpt_icon":0},{"id":"2533692720","title":"关税动荡日，名私募们的仓位都在近年来的高点……","url":"https://stock-news.laohu8.com/highlight/detail?id=2533692720","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533692720?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 15:39","pubTimestamp":1746689948,"startTime":"0","endTime":"0","summary":"医药生物、房地产等配置升温","market":"sg","thumbnail":"https://img3.gelonghui.com/c3726-9149b6ef-1eca-431e-9cc2-8de733fec32b.png?guru_height=616&guru_width=940","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/c3726-9149b6ef-1eca-431e-9cc2-8de733fec32b.png?guru_height=616&guru_width=940"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2147435","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1574","BK1515","09939","BK1161"],"gpt_icon":0},{"id":"2533979865","title":"消息称特斯拉中国4月份批发销量不到6万辆 同比环比双双下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2533979865","media":"TechWeb.com.cn","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533979865?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 15:27","pubTimestamp":1746689238,"startTime":"0","endTime":"0","summary":"在比亚迪、吉利和上汽通用五菱之后的则是特斯拉中国，他们4月份的批发销量为58,459辆。特斯拉中国4月份的批发销量不到6万辆，也就意味着同比环比均有下滑。乘联分会此前发布的报告显示，特斯拉中国去年4月份的批发销量为62,167量，仅次于比亚迪，排在第2；今年3月份的批发销量则是78,828量，仅次于比亚迪和吉利汽车，排在第3。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508152718a4765121&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508152718a4765121&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348827113.USD","LU0588545490.SGD","LU0708995583.HKD","LU0348766576.USD","LU2097828714.EUR","01211","LU1719994722.HKD","LU0359201885.HKD","LU0348825331.USD","IE00BD6J9T35.USD","002594","LU1794554557.SGD","LU0274383008.USD","LU0650527681.SGD","LU0594300419.USD","LU1861219969.SGD","BK1589","LU0054450605.USD","LU0348767384.USD","LU0505663152.USD","LU0516423174.USD","LU0819123356.HKD","LU0289961442.SGD","LU0449509016.USD","LU1861214812.USD","LU2249611893.SGD","81211","SG9999006514.SGD","LU0463099449.HKD","HYDD.SI","LU0531971595.HKD","LU1303224171.USD","LU0254981946.USD","LU0269904917.USD","LU0229945570.USD","LU0143863784.USD","LU0605514214.HKD","BK1119","BYDDY","00285","LU0588545730.USD","LU0871576103.HKD","LU0561508036.HKD","SG9999015945.SGD","LU0516422366.SGD","BK1515","LU1808992512.USD","LU0516423091.SGD","BK1582","LU0516422440.USD"],"gpt_icon":0},{"id":"2533924839","title":"【券商聚焦】中泰国际5月医药行业投资策略：续推高附加价值的创新药生产商","url":"https://stock-news.laohu8.com/highlight/detail?id=2533924839","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533924839?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 15:13","pubTimestamp":1746688427,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰国际发布医药行业5月投资策略。依达方目前是在中国销售，而且是2024年5月刚刚获批，今年4月又新增第二项适应症，因此该行认为2025年该产品销量仍将快速增加。依达方是公司获批的第二款产品，因此初步预计公司的产品销售收入在2025年仍将实现较快增长。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1958338","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","BK1191","IE00B543WZ88.USD","01801","06978","BK1515","03692","LU1969619763.USD","BK1589","LU1720050803.USD","LU2328871848.SGD","159992","09926","IE00BPRC5H50.USD","BK1583","LU0348784397.USD","BK1574","01177","LU0348783233.USD","LU0417516571.SGD","LU2488822045.USD","BK1161","LU1794554557.SGD","BK1521"],"gpt_icon":0},{"id":"2533217509","title":"76亿并购梦碎、15个月努力归零，负增长下的新诺威危机四伏","url":"https://stock-news.laohu8.com/highlight/detail?id=2533217509","media":"钛媒体","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533217509?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 14:49","pubTimestamp":1746686954,"startTime":"0","endTime":"0","summary":"另外，新诺威还表示，目前，公司各项业务经营情况正常，本次交易的终止对公司现有生产经营活动不会造成重大不利影响。一场不被看好的重大整合在收购石药百克的两个关键信息披露节点，新诺威均出现大跌。而在2022年至2024年上半年，石药百克分别实现净利润6.21亿元、7.85亿元、3.9亿元与低承诺对应的是新诺威给出的高估值。公司陷入负增长，创新药业务要担责在2024年及2025年一季度，新诺威均出现营收、利润双降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050815011494f02809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050815011494f02809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0140636845.USD","BK1515","IE00B543WZ88.USD","IE0008369823.USD","LU1226287875.USD","IE00B031HY20.USD","LU1226287792.SGD","BK1191","IE00BZ08YT58.USD","LU1152091168.USD","LU1993786604.SGD","IE0008368742.USD","LU1226288253.USD","LU0880133367.SGD","LU1960683339.HKD","LU0067412154.USD","LU0501845795.SGD","LU1226288170.HKD","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1951186391.HKD","IE00B5MMRT66.SGD","LU1807302812.USD","SG9999004220.SGD","LU0072913022.USD","LU1226287529.USD","IE00BZ08YS42.EUR","BK1521","01093","LU1152091754.HKD","LU0326950275.SGD"],"gpt_icon":0},{"id":"2533354921","title":"中国生物制药(01177)出现大手卖出150万股，成交价$3.85，涉资577.5万","url":"https://stock-news.laohu8.com/highlight/detail?id=2533354921","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533354921?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 14:42","pubTimestamp":1746686520,"startTime":"0","endTime":"0","summary":"[大手成交]中国生物制药(01177)在下午02:42出现大手卖出，成交量为150万，成交价为港币$3.85，涉资577.5万。至目前为止，股价升0.522%，今日最高价为$3.89，而最低价为$3.81，总成交量为4.263千万股，总成交金额港币$1.637亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2505087671/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1521","BK1191","BK1589","BK1515","01177"],"gpt_icon":0},{"id":"2533239389","title":"北京免疫方舟医药科技有限公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2533239389","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533239389?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 14:06","pubTimestamp":1746684381,"startTime":"0","endTime":"0","summary":"5月8日，据CDE官网消息，北京免疫方舟医药科技有限公司联合申请药品“IMB071703注射液”，获得临床试验默示许可，受理号CXSL2500189。北京免疫方舟医药科技有限公司，成立于2017年，位于北京市，是一家以从事科技推广和应用服务业为主的企业。通过天眼查大数据分析，北京免疫方舟医药科技有限公司参与招投标项目4次，知识产权方面有商标信息5条，专利信息19条，此外企业还拥有行政许可6个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/08140650218876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","BK1576","159938","BK1161","BK1583","03347","09939","BK1141","BK1574"],"gpt_icon":0},{"id":"2533923557","title":"同源康医药-B盘中异动 快速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533923557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533923557?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 13:51","pubTimestamp":1746683501,"startTime":"0","endTime":"0","summary":"2025年05月08日下午盘13时51分，同源康医药-B股票出现波动，股价大幅下挫5.02%。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.03%。消息层面，截至13时51分，《同源康医药-B：2024年亏损3.87亿元》资讯为影响同源康医药-B的重要信息。该信息摘要如下：中证智能财讯同源康医药-B4月29日披露2024年度报告。以4月29日收盘价计算，同源康医药-B目前市净率约19.8倍，市销率约86815.03倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081351419752ce7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081351419752ce7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","BK1515","BK1574","09939"],"gpt_icon":0},{"id":"2533694063","title":"罗氏宣布投资超20亿人民币 在沪新建生物制药生产基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2533694063","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533694063?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 13:44","pubTimestamp":1746683049,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0273","BK0020","BK0059","BK0190","BK0099","BK1161","BK0184","BK0053","BK0012","BK1191","BK1574","09939","BK0188","BK0183","01477","600895","BK0075","159938","BK0028","BK1515","BK0011"],"gpt_icon":0},{"id":"2533929301","title":"歌礼制药-B：股价涨 3.32% 减肥药催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2533929301","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533929301?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 12:42","pubTimestamp":1746679365,"startTime":"0","endTime":"0","summary":"歌礼制药近日称将在西班牙马拉加举行的第 32 届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物 ASC47 的早期研究。此外，有传闻称“世卫组织计划首次将减肥药纳入基本药物目录以治疗成人肥胖症”。5 月 7 日，世卫组织正式回应，治疗成年肥胖患者的指南正按程序全面制定，预计 2025 年 8 月或 9 月出台最终方案。中信证券此前指，预计后续相关事件将对减肥药板块形成反复催化，有望形成跨年度的主题行情。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081441239752da30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081441239752da30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1574","01477","BK1191","BK1161","BK1515"],"gpt_icon":0},{"id":"2533494912","title":"快递总裁收入曝光：李杰、刘强东、王卫，谁是快递行业的超级霸总","url":"https://stock-news.laohu8.com/highlight/detail?id=2533494912","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533494912?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 12:17","pubTimestamp":1746677836,"startTime":"0","endTime":"0","summary":"近年，总裁短剧爆火，剧中总裁们动辄年入数亿、挥金如土的剧情令无数人艳羡。但现实中，那些掌管着庞大企业的总裁们，真实年薪究竟咋样呢？尤其与大众生活息息相关的快递行业，其掌舵者的年收入究竟是多少呢？随着2024年快递公司年报陆续披露，答案逐渐揭晓。翻阅2024年快递公司年报，极兔、京东、中通等头部企业掌舵者的薪酬数字堪称“碾压级”的存在。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/256746","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0431992006.USD","LU0456827905.SGD","89618","LU0417516902.SGD","BK4579","BK1575","LU0456846285.SGD","IE0032431581.USD","LU0348825331.USD","SG9999002463.SGD","LU0320764599.SGD","LU1282651048.USD","LU0348805143.USD","LU1720050803.USD","BK1515","LU0588545490.SGD","BK4524","LU0359201612.USD","LU1481107354.HKD","LU0791591158.USD","BK4504","LU1282651121.HKD","LU0708995583.HKD","LU0051755006.USD","LU0456842615.SGD","06618","LU0259732245.USD","LU0244354667.USD","LU0326950275.SGD","BK4614","BK1610","BK4558","LU0469268626.HKD","LU1282649810.SGD","LU0149721374.USD","JD","86618","09618","BK1589","IE0008368742.USD","BK4503","IE00BGV7N243.SGD","LU0345775950.USD","LU0499858602.USD","LU1770036033.HKD","LU1328277881.USD","BK1591","BK1615","LU0039217434.USD","BK1583"],"gpt_icon":1},{"id":"2533294914","title":"歌礼制药-B股价上涨超3% 将公布肥胖症药物早期研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533294914","media":"DoNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533294914?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 12:06","pubTimestamp":1746677162,"startTime":"0","endTime":"0","summary":"5月8日，歌礼制药-B（01672）午前股价上涨3.32%，报6.54港元。公司将在西班牙马拉加举行的第32届欧洲肥胖症大会上报告肥胖症候选药物ASC47的早期研究结果。ASC47为歌礼自主研发的小分子激动剂，已获FDA批准与司美格鲁肽联用治疗肥胖症。此外，世卫组织计划制定成年肥胖患者治疗指南，预计2025年8月或9月出台。业内人士分析，减肥药板块有望形成跨年度主题行情。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050812081994f00378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050812081994f00378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","01477","BK1161","BK1191","01672"],"gpt_icon":0},{"id":"2533943501","title":"港股异动 | 歌礼制药-B(01672)涨超3% 将公布肥胖症候选药物ASC47早期研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533943501","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533943501?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 11:30","pubTimestamp":1746675049,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，歌礼制药-B涨超3%，截至发稿，涨3.48%，报6.55港元，成交额743.52万港元。消息面上，歌礼制药近日宣布将在西班牙马拉加举行的第32届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物ASC47的早期研究。美国食品药品监督管理局已批准ASC47与司美格鲁肽联用治疗肥胖症的新药临床试验申请。此外，有传闻称“世卫组织计划首次将减肥药纳入基本药物目录以治疗成人肥胖症”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","01672","BK1574","01477","BK1161"],"gpt_icon":0},{"id":"2533000948","title":"比亚迪(01211.HK)及青山控股退出智利锂生产投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2533000948","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533000948?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 11:13","pubTimestamp":1746673980,"startTime":"0","endTime":"0","summary":"智利政府经济开发机构Corfo表示，中国电动车生产商比亚迪(01211.HK) 及金属集团青山控股退出在当地兴建锂阴极工厂的计划，有关项目受锂价下滑打击。《路透》报道，青山控股退出投资2.33亿美元生产12万公吨磷酸铁锂的计划。智利国家资源部亦披露比亚迪已于1月提交有意退出计划的通知。比亚迪去年押后在当地的2.9亿美元厂房项目，项目预计每年生产5万吨磷酸铁锂用于阴极。智利为全球第二大锂生产国，拟发展更多本土锂加工产业。锂是电动车电池的关键金属。(fc/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-05-07 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230710124610420_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230710124610420_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1438540/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1580142542.USD","SG9999006514.SGD","LU0175139822.USD","LU0516422952.EUR","BK1594","LU0084288322.USD","LU2399975544.HKD","LU0819123356.HKD","LU0516423174.USD","LU1064131003.USD","LU1969619763.USD","LU0359201612.USD","LU1997244956.HKD","LU2778985437.USD","002594","LU0823414478.USD","LU0229945570.USD","LU2580892862.HKD","LU0143863784.USD","LU0348735423.USD","00285","LU0540923850.HKD","LU2495084118.USD","LU1961090484.USD","LU1880383440.USD","BK0155","LU0511384066.AUD","LU1861219969.SGD","LU0165289439.USD","BYDDY","SG9999015945.SGD","LU0269904917.USD","HYDD.SI","BK0183","LU0417516738.SGD","BK1515","EVS.SI","LU0823426480.USD","LU0289961442.SGD","BK1509","LU0326950275.SGD","LU2249611893.SGD","LU1064130708.USD","01211","81211","LU1781817850.SGD","LU2663582299.SGD","SG9999015978.USD","BK1149","LU0307460666.USD"],"gpt_icon":0},{"id":"2533342917","title":"开拓药业扳回一局","url":"https://stock-news.laohu8.com/highlight/detail?id=2533342917","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533342917?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 10:38","pubTimestamp":1746671880,"startTime":"0","endTime":"0","summary":"开拓药业核心产品KX-826（福瑞他恩）与米诺地尔联合治疗男性脱发效果显著，优于米诺地尔单药，引发市场关注。KX-826是雄激素受体拮抗剂，曾历经挫折，现以化妆品形式上市并贡献营收，联用研究再显成效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050810401694efec9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050810401694efec9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","09939","BK1574","BK1161"],"gpt_icon":0},{"id":"2533691721","title":"比亚迪申请一种负极片及其制备方法等专利，减少负极片膨胀提升电池循环性能","url":"https://stock-news.laohu8.com/highlight/detail?id=2533691721","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533691721?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 10:03","pubTimestamp":1746669786,"startTime":"0","endTime":"0","summary":"专利摘要显示，本申请公开了一种负极片及其制备方法、电池及用电设备，负极片包括集流体，设置在所述集流体至少一侧的负极活性层，所述负极活性层包括形状记忆聚合物，所述形状记忆聚合物包括硬段聚合物和软段聚合物形成的嵌段共聚物。本申请提供的负极片，在负极活性层引入形状记忆聚合物，可以在负极活性材料膨胀时引发变形效应而吸收应力，从而减少对隔膜的压缩而保障电解液扩散通路，减少负极片膨胀，提升电池的循环性能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050810150497529a15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050810150497529a15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348767384.USD","LU2097828714.EUR","SG9999015978.USD","LU0505663152.USD","LU2360107325.USD","LU0588545730.USD","LU0164872284.USD","LU1242518857.USD","LU0054450605.USD","LU0543330566.HKD","LU0269904917.USD","LU0819121731.USD","LU0634319403.HKD","LU0516422440.USD","LU0359201612.USD","HYDD.SI","LU0823414478.USD","LU1861214812.USD","LU1868837722.USD","002594","LU0516423174.USD","LU0823426480.USD","LU1242518931.SGD","LU2476274308.USD","LU1720050803.USD","BK1610","SG9999006514.SGD","LU0084288322.USD","LU1303224171.USD","LU0823426308.USD","LU0289961442.SGD","LU1251922891.USD","LU0348805143.USD","BYDDY","00285","LU0164865239.USD","LU0588546209.SGD","LU1880383366.USD","01211","81211","BK1504","LU0540923850.HKD","LU1719994722.HKD","LU1861219969.SGD","LU0229945570.USD","LU0605514214.HKD","LU0865486749.SGD","BK1515","LU0214875030.USD","LU0828238088.HKD"],"gpt_icon":1},{"id":"2533639915","title":"恒生指数、恒生科技指数盘初转涨，新能源物料、医药外包概念、军工股等涨幅居前。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533639915","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533639915?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 09:34","pubTimestamp":1746668049,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bc6505608fcad7c1edf7e61deb6dcbeb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["399941","000941.SH","09939","161024","159875","160640","BK1515","HSI","02833","513600","BK1574","HSImain","159938","HHImain","MCHmain","HSTECH","MHImain","BK1161"],"gpt_icon":0},{"id":"2533337471","title":"人工智能赋能医药全产业链！“智造”创新药指日可待？","url":"https://stock-news.laohu8.com/highlight/detail?id=2533337471","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533337471?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 09:07","pubTimestamp":1746666429,"startTime":"0","endTime":"0","summary":"AI赋能药物发现在药物发现阶段，AI的突破尤为显著。AI赋能创新药生产制造生产制造环节也在发生质变。最新出台的医药工业数智化转型方案明确提出，到2027年要建成100个数智化药械工厂，培育30家AI医药服务商，并通过数据共享平台打破“信息孤岛”。六、以上基金由银华基金依照有关法律法规及约定申请募集，并经中国证券监督管理委员会许可注册。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050809205294efd306&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050809205294efd306&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","BK1583","09926","LU1969619763.USD","BK1574","09939","LU2328871848.SGD","06978","LU2488822045.USD","BK1161","BK1589","BK1515","02269","02359"],"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":8,"totalSize":323,"code":"91000000","status":"200"}]}}